149 related articles for article (PubMed ID: 36070211)
1. How we approach coagulopathy with vascular anomalies.
Mack JM; Crary SE
Pediatr Blood Cancer; 2022 Aug; 69 Suppl 3():e29353. PubMed ID: 36070211
[TBL] [Abstract][Full Text] [Related]
2. [Acute complications of vascular anomalies in childhood].
Fließer M; Teichler A; Höger PH
Hautarzt; 2017 Oct; 68(10):790-795. PubMed ID: 28815311
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analyses of Coagulation Parameters in Patients with Vascular Anomalies.
Kapp FG; Schneider C; Holm A; Glonnegger H; Niemeyer CM; Rößler J; Zieger B
Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551267
[TBL] [Abstract][Full Text] [Related]
4. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus.
Cashell J; Smink GM; Helm K; Xavier F
Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028
[TBL] [Abstract][Full Text] [Related]
5. Kaposiform Hemangioendothelioma with Kasabach-Merritt Phenomenon.
Pati S; Das MK; Rana A; Das E; Sarkar S; Sherpa N; Datta S
Indian J Pediatr; 2021 Nov; 88(11):1142-1144. PubMed ID: 34106442
[TBL] [Abstract][Full Text] [Related]
6. Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals.
Croteau SE; Liang MG; Kozakewich HP; Alomari AI; Fishman SJ; Mulliken JB; Trenor CC
J Pediatr; 2013 Jan; 162(1):142-7. PubMed ID: 22871490
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus for Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon in Two Infants.
Wang Y; Kong L; Sun B; Cui J; Shen W
J Craniofac Surg; 2020 Jun; 31(4):1074-1077. PubMed ID: 32176003
[TBL] [Abstract][Full Text] [Related]
8. A not so harmless mass: Kaposiform hemangioendothelioma complicated by a Kasabach-Merritt phenomenon.
Tribolet S; Hoyoux C; Boon LM; Cheruy C; Demarche M; Jamblin P; Roberti A; Willemaers V; Viellevoye R; Rigo V; Broux I
Arch Pediatr; 2019 Sep; 26(6):365-369. PubMed ID: 31353149
[TBL] [Abstract][Full Text] [Related]
9. Successful Everolimus Treatment of Kaposiform Hemangioendothelioma With Kasabach-Merritt Phenomenon: Clinical Efficacy and Adverse Effects of mTOR Inhibitor Therapy.
Matsumoto H; Ozeki M; Hori T; Kanda K; Kawamoto N; Nagano A; Azuma E; Miyazaki T; Fukao T
J Pediatr Hematol Oncol; 2016 Nov; 38(8):e322-e325. PubMed ID: 26907642
[TBL] [Abstract][Full Text] [Related]
10. Retroperitoneal kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon and obstructive jaundice: A retrospective series of 3 patients treated with sirolimus.
Yao W; Li K; Wang Z; Dong K; Zheng S
Pediatr Dermatol; 2020 Jul; 37(4):677-680. PubMed ID: 32212177
[TBL] [Abstract][Full Text] [Related]
11. Coagulation issues in vascular anomalies.
Ricci KW; Brandão LR
Semin Pediatr Surg; 2020 Oct; 29(5):150966. PubMed ID: 33069295
[TBL] [Abstract][Full Text] [Related]
12. Splenic kaposiform hemangioendothelioma presenting as insidious consumptive coagulopathy.
Goldenberg M; Shiel M; Subramanian S; Kalpatthi R; Reyes-Múgica M; Nolfi-Donegan D
Am J Hematol; 2021 Dec; 96(12):1708-1714. PubMed ID: 34622468
[No Abstract] [Full Text] [Related]
13. Long-term outcome for kaposiform hemangioendothelioma: A report of two cases.
Schaefer BA; Wang D; Merrow AC; Dickie BH; Adams DM
Pediatr Blood Cancer; 2017 Feb; 64(2):284-286. PubMed ID: 27701822
[TBL] [Abstract][Full Text] [Related]
14. Kaposiform hemangioendothelioma arising in the deltoid muscle without the Kasabach-Merritt phenomenon.
Tamai N; Hashii Y; Osuga K; Chihara T; Morii E; Aozasa K; Yoshikawa H
Skeletal Radiol; 2010 Oct; 39(10):1043-6. PubMed ID: 20309545
[TBL] [Abstract][Full Text] [Related]
15. Kaposiform haemangioendothelioma: clinical features, complications and risk factors for Kasabach-Merritt phenomenon.
Ji Y; Yang K; Peng S; Chen S; Xiang B; Xu Z; Li Y; Wang Q; Wang C; Xia C; Li L; Liu X; Lu G; Yang G; Wu H
Br J Dermatol; 2018 Aug; 179(2):457-463. PubMed ID: 29603128
[TBL] [Abstract][Full Text] [Related]
16. Platelet functional abnormalities in pediatric patients with kaposiform hemangioendothelioma/Kasabach-Merritt phenomenon.
Martyanov AA; Tesakov IP; Khachatryan LA; An OI; Boldova AE; Ignatova AA; Koltsova EM; Korobkin JD; Podoplelova NA; Svidelskaya GS; Yushkova E; Novichkova GA; Eble JA; Panteleev MA; Kalinin DV; Sveshnikova AN
Blood Adv; 2023 Sep; 7(17):4936-4949. PubMed ID: 37307200
[TBL] [Abstract][Full Text] [Related]
17. Anesthestic management of Kassabach-Meritt Phenomenon in an adult: case report.
Elkoundi A; Samali M; Kartite N; Tbouda M; Bensghir M; Haimeur C
BMC Anesthesiol; 2016 Nov; 16(1):109. PubMed ID: 27829366
[TBL] [Abstract][Full Text] [Related]
18. Kaposiform hemangioendothelioma in children: a benign vascular tumor with multiple treatment options.
Schmid I; Klenk AK; Sparber-Sauer M; Koscielniak E; Maxwell R; Häberle B
World J Pediatr; 2018 Aug; 14(4):322-329. PubMed ID: 30054848
[TBL] [Abstract][Full Text] [Related]
19. Kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon: ultrastructural observation and immunohistochemistry staining reveal the trapping of blood components.
Yuan SM; Hong ZJ; Chen HN; Shen WM; Zhou XJ
Ultrastruct Pathol; 2013 Dec; 37(6):452-5. PubMed ID: 24134598
[TBL] [Abstract][Full Text] [Related]
20. Additive value of transarterial embolization to systemic sirolimus treatment in kaposiform hemangioendothelioma.
Brill R; Uller W; Huf V; Müller-Wille R; Schmid I; Pohl A; Häberle B; Perkowski S; Funke K; Till AM; Lauten M; Neumann J; Güttel C; Heid E; Ziermann F; Schmid A; Hüsemann D; Meyer L; Sporns PB; Schinner R; Schmidt VF; Ricke J; Rössler J; Kapp FG; Wohlgemuth WA; Wildgruber M
Int J Cancer; 2021 May; 148(9):2345-2351. PubMed ID: 33231291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]